drugset / Trial / NCT00799058
A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States
RandomizedParallel-groupDouble-blindPrevention
Summary
A double-blind, randomized, placebo-controlled Phase I/II trial to evaluate the safety of dapivirine Gel 4759, 0.05% 2.5 g and dapivirine Gel 4789, 0.05% 2.5 g formulations as compared to the vaginal HEC-based Universal placebo gel, 2.5 g in healthy HIV-negative women
Timeline
- Start
- 2009-07-06
- Primary completion
- 2011-01-08
- Completion
- 2011-01-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | dapivirine | Small molecule | 0.05 % | Other |
| Comparator | dapivirine | Small molecule | 2.5 g | Other |